Authors: Schwarz, T Siegert, G Mikulin, U Gehrisch, S Runge, E Berg, LP Koch, R Schellong, SM

Citation: T. Schwarz et al., Patients with persistent APC-resistance without factor V Leiden mutation, VASA, 30(1), 2001, pp. 24-27

Authors: Siegert, G Kostka, H Gehrisch, S Schwarz, T Schellong, S Jaross, W

Citation: G. Siegert et al., Method-dependent influence of certain polymorphisms in the factor VB-domain on the response to activated protein C, BL COAG FIB, 11(6), 2000, pp. 519-527

Authors: Kostka, H Siegert, G Schwarz, T Gehrisch, S Kuhlisch, E Schellong, S Jaross, W

Citation: H. Kostka et al., Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients, THROMB RES, 99(6), 2000, pp. 539-547

Authors: Gehrisch, S Kostka, H Tiebel, M Patzak, A Paetzold, A Julius, U Schroeder, HE Hanefeld, M Jaross, W

Citation: S. Gehrisch et al., Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemia, J MOL MED-J, 77(10), 1999, pp. 728-734

Authors: Bochmann, H Gehrisch, S Jaross, W

Citation: H. Bochmann et al., The gene structure of the human growth factor bound protein GRB2, GENOMICS, 56(2), 1999, pp. 203-207

Authors: Knofler, R Siegert, E Lauterbach, I Taut-Sack, H Siegert, G Gehrisch, S Muller, D Rupprecht, E Kabus, M

Citation: R. Knofler et al., Clinical importance of prothrombotic risk factors in pediatric patients with malignancy - impact of central venous lines, EUR J PED, 158, 1999, pp. S147-S150